Everolimus is associated with a reduced incidence of cytomegalovirus infection followingde novocardiac transplantation

CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages

(2012) M. Poglitsch et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of Cytomegalovirus Disease in D+/R- Kidney Transplant Patients Receiving 6 Months Low-Dose Valganciclovir Prophylaxis

(2011) F. L. Luan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients

(2010) H. Tedesco Silva Jr. et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Strategies for managing cytomegalovirus in transplant recipients

(2010) Raymund R Razonable   EXPERT OPINION ON PHARMACOTHERAPY

Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication

(2010) N. J. Moorman et al.   JOURNAL OF VIROLOGY

Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study

(2010) J.F. Delgado et al.   Transplant Infectious Disease

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

Cytomegalovirus in Solid Organ Transplant Recipients

(2009) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prophylaxis Versus Preemptive Anti-cytomegalovirus Approach for Prevention of Allograft Vasculopathy in Heart Transplant Recipients

(2009) Luciano Potena et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

A metabolic switch to memory

(2009) Martin Prlic et al.   NATURE

mTOR regulates memory CD8 T-cell differentiation

(2009) Koichi Araki et al.   NATURE

Inhibition of Polyomavirus BK-Specific T-Cell Responses by Immunosuppressive Drugs

(2009) Adrian Egli et al.   TRANSPLANTATION

Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients

(2009) Hans B. Lehmkuhl et al.   TRANSPLANTATION

Prevention of Posttransplant Cytomegalovirus Disease and Related Outcomes with Valganciclovir: A Systematic Review

(2008) H-Y. Sun et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation

(2008) Rafael San Juan et al.   CLINICAL INFECTIOUS DISEASES